QoL Findings from PALLAS Trial are Published in ESMO Open – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X about a paper by M.J. Naughton et al. published in ESMO Open:
“New in ESMO Open. Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early Breast Cancer.”
Title: Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)
Authors: M.J. Naughton, D.M. Zahrieh, M. Gnant, N. Zdenkowski, J. Lemieux, J.J. Mao, V. Bjelic-Radisic, E. Shinn, M. Balic, C. Thomssen, J.L. Meisel, G.M. Ruiz, S. Loibl, C. Isaacs, D. Cameron, F.M. Henao-Carrasco, M.P. Goetz, C.F. Singer, G. Werutsky, H.S. Rugo, M. Vetter, L.-M. Tseng, K. Miller, F. Fitzal, J.M. Gil Gil, H. Park, B. Linderholm, E. Bajetta, Z. Dayao, A. Prat, K. Ehrhardt, O. Metzger, A. Arahmani, E.H. Law, A.H. Partridge, L.A. Carey, A. Zoroufy, A.C. Dueck, P. O’Brien, D. Hlauschek, A. DeMichele, E.L. Mayer
You can read the Full Article in ESMO Open.
More posts featuring Dana-Farber’s Breast Oncology Center.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023